Insights

Advancing the science and practice of sleep medicine through evidence-based insights and data-driven analysis.

insights

Filter

Category

Early ID & risk stratification Longitudinal care & outcomes Care system transformation Scalable diagnosis & access Continuity of sleep care

Content type

Article Video Opinion

Longitudinal care & outcomes

GLP-1s, PAP and the future of multimodal sleep therapy: OSA care requires clearer clinical guidance

GLP-1/GIP therapies are reshaping OSA care, but their arrival has exposed a critical guideline gap. Current guidelines lack operational direction on reassessment, multimodal sequencing and therapy discontinuation, risking unverified disease resolution assumptions and unsafe therapy abandonment.

Early ID & risk stratification

OSA underdiagnosis: A world of difference, a common challenge

At World Sleep 2025, international experts shared firsthand insights on what's broken and what's working in global OSA diagnosis. Hear the discussion on tackling missed diagnosis, challenging outdated norms and building new models of care.

Care system transformation

Revisiting OSA care standards: aligning treatment with phenotype

Obstructive sleep apnea (OSA) is biologically heterogeneous, and distinct phenotypes show different treatment responses and adherence patterns. The current uniform, AHI‑driven care is misaligned with how the disease actually presents in many patients.

Care system transformation

Capitation is not value: Rewarding continuity, not containment

For payers, the central question is not how to cap costs in sleep care, but how to sustain measurable reductions in downstream utilization over time.

Longitudinal care & outcomes

Embedding life context into OSA therapy selection and adherence frameworks

In sleep therapy, biology sets the stage, but life circumstances often decide the outcome.

Continuity of sleep care

The missing link: Re-engagement and continuity in OSA care

OSA is chronic yet care systems treat drop-off as an endpoint. Re-engagement and continuity pathways are essential to improving outcomes and reducing inequities.

Care system transformation

Why the OSA journey needs long-term, adaptive treatment models

OSA is chronic and affects nearly a billion people, yet care remains rigid and binary. It’s time for a model that’s flexible and supports long-term care.

Scalable diagnosis & access

Underdiagnosed and overlooked:The OSA challenge

OSA is a prevalent yet underdiagnosed disease, currently affecting over 50 million adults in the United States, yet up to 80% of cases remained undiagnosed^{1, 2} — demanding urgent action to close the care gap.

Longitudinal care & outcomes

The economic value of treating OSA with PAP therapy

By reducing acute care costs and improving management of high-cost comorbidities, PAP therapy offers a compelling opportunity to reduce total cost of care.

Longitudinal care & outcomes

Action needed to navigate the rising tide of OSA

Immediate action is needed by multiple sleep stakeholders to ensure the future burden of OSA can be clinically managed by sleep specialists and primary care providers (PCPs)

Care system transformation

Sleep care reform is long overdue

Making sleep essential requires more than recognition—it demands policy, funding, and clinical integration across systems of care.

Care system transformation

The high price of ignoring sleep

Recognizing sleep as essential marks progress, but real-world change in care delivery, education, and funding remains critically overdue.

Care system transformation

A call to invest in rest: Better sleep improves mental health

Along with the economy, productivity and health systems, we must invest in rest as a serious policy principle. It is that integral to our health.

Early ID & risk stratification

Beyond AHI: The search for more robust OSA diagnostic criteria

AHI as the sole or primary OSA diagnostic criteria puts too many people at risk by preventing treatment for those who need it.

Early ID & risk stratification

How AHI came to be the standard diagnostic measure

The AHI and OSA are deeply intertwined, but questions have been asked about AHI as a metric of OSA diagnosis and classification from the beginning.

Early ID & risk stratification

Beyond the stereotypes: Obstructive sleep apnea in women

A growing body of research shows how gender biases and stereotypes of obstructive sleep apnea stand in the way of women receiving the help they need.

Longitudinal care & outcomes

The insufficiency of today's approach to COMISA care

Despite clear recognition as a standalone condition, COMISA remains not only underdiagnosed but poorly managed, falling through many systemic cracks.

Longitudinal care & outcomes

The increasing burden of insomnia and COMISA

Clinicians, policymakers and industry leaders must give greater attention to the impact of COMISA on individuals, health systems and economies.

Scalable diagnosis & access

COMISA: The underdiagnosis continues

As comorbid insomnia and OSA (COMISA) is recognized as a standalone condition, diagnostic approaches lack, resulting in high rates of underdiagnosis.

Longitudinal care & outcomes

CBT-I addresses root causes of insomnia, not just symptoms

CBT-I ushers in a new level of promise for patients with insomnia as a true treatment that is non-invasive and free of pharmacological interactions.

Early ID & risk stratification

How P4 medicine can improve diagnosis and treament of OSA

Current approaches to OSA leave many struggling, often going undiagnosed and untreated. A P4 mindset can shift thinking to identify at-risk patients earlier.

Longitudinal care & outcomes

The value of clinical trial and real-world data together

RWE with RCTs blends theory with practice to increase patient representation and identify long-term trends, enhancing the ability to advance patient care.

No result found

scroll-to-top

Privacy|Terms of use |©2026 Resmed|All rights reserved